Envista Corp (NVST)
undefined
undefined%
At close: undefined
19.47
-0.10%
After-hours Dec 13, 2024, 07:00 PM EST

Company Description

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions.

The company is headquartered in Brea, California and currently employs 12,800 full-time employees.

The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone.

The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables.

Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products.

Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Envista Corp
Envista  Corp logo
Country United States
IPO Date Sep 18, 2019
Industry Medical - Equipment & Services
Sector Healthcare
Employees 12,800
CEO Paul A. Keel

Contact Details

Address:
200 S Kraemer Blvd Bldg E
Brea, California
United States
Website http://www.envistaco.com/

Stock Details

Ticker Symbol NVST
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001757073
CUSIP Number 29415F104
ISIN Number US29415F1049
Employer ID 83-2206728
SIC Code 3843

Key Executives

Name Position
Paul A. Keel Chief Executive Officer & Director
Andrew Chen Chief Information Officer
Eric D. Hammes Chief Financial Officer
Faez Kaabi Vice President, Chief Accounting Officer & Corporate Controller
Filippo Impieri Senior Vice President of Emerging Markets
Mark E. Nance J.D. Senior Vice President, General Counsel & Secretary
Mischa M. Reis Senior Vice President of Strategy & Corporate Development
Paul Sumilas Chief Compliance Officer
Stephen Keller Vice President of Investor Relations
Suraj Satpathy Chief Human Resources officer

Latest SEC Filings

Date Type Title
Nov 25, 2024 3 Filing
Nov 25, 2024 3 Filing
Nov 20, 2024 8-K Current Report
Nov 12, 2024 SCHEDULE 13G Filing
Nov 08, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 04, 2024 4 Filing
Oct 30, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Sep 19, 2024 4 Filing
Sep 19, 2024 S-8 Filing